Publications by authors named "Philippe Alexandre Cassier"

Claim this Profile
R
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis.
Sophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, Jean Philippe Metges, Simon Pernot, Philippe Alexandre Cassier

Nat Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.
Sophie Cousin, Jean-Philippe Guégan, Kohei Shitara, Lola Jade Palmieri, Jean Philippe Metges, Philippe Alexandre Cassier

Mol Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.
Jean-Luc Van Laethem, Ivan Borbath, Hans Prenen, Karen Paula Geboes, Aurélien Lambert, Philippe Alexandre Cassier

Lancet Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.
Christophe Le Tourneau, Jean-Pierre Delord, Nuria Kotecki, Edith Borcoman, Carlos Gomez-Roca, Philippe Alexandre Cassier

Br J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study.
Martin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, Alejandro Navarro, Ross A Soo, Philippe Alexandre Cassier

Lancet Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium.
Isabelle Ray-Coquard, Ioana Braicu, Regina Berger, Sven Mahner, Jalid Sehouli, Philippe Alexandre Cassier

Front Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
Anne-Laure Giraudet, Philippe Alexandre Cassier, Chicaco Iwao-Fukukawa, Gwenaelle Garin, Jean-Noël Badel

BMC Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome.
Pauline Rochefort, Antoine Italiano, Valérie Laurence, Nicolas Penel, Audrey Lardy-Cleaud, Philippe Alexandre Cassier

Sci Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis